查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1477966

3D 生物列印市场：依地区划分的全球产业分析、规模、占有率、成长、趋势、预测，2024-2031 年

3D Bioprinting Market by Product Type, End-Users, and Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031
出版日期: | 出版商: Persistence Market Research | 英文 250 Pages | 商品交期: 2-5个工作天内

价格
简介目录

Persistence Market Research 发布了全球 3D 生物列印市场的详细分析，提供了 2024 年至 2031 年主要市场趋势、成长驱动因素/课题以及新兴趋势的见解。本报告旨在为利害关係人提供详细的数据和统计数据，以指导这一不断发展的领域的策略决策。

全球3D生物列印市场预计将快速成长，2024年至2031年复合年增长率为15%。这一成长预计将使市场规模从 2024 年的估计 25 亿美元扩大到 2031 年底的约 66 亿美元。

重要见解

  • 预计市场价值（2024年）：25亿美元
  • 预计市值（2031年）：66亿美元
  • 全球市场成长率（2024-2031年复合年增长率）：15%

3D 生物列印市场 - 研究范围：

3D 生物列印技术允许使用积层製造流程创建复杂的生物结构。它已成为组织工程、再生医学和药物研究的重要工具。技术的快速进步和对器官移植替代品不断增长的需求正在推动该市场的成长。本报告的范围涵盖了 3D 生物列印的持续发展、其在各个领域的应用以及塑造该行业的广泛趋势。

市场驱动因素：

3D生物列印市场的快速成长是由多种因素推动的。随着器官移植需求的不断增长和供体器官的短缺，研究人员正在探索 3D 生物列印作为替代方案。材料和生物列印技术的进步使得复杂的组织结构的创建成为可能，扩大了再生医学的潜力。此外，製药业正在采用 3D 生物列印进行药物测试和开发，从而实现更精确和更具成本效益的研究。此外，政府资助和学术研究正在促进创新和新产品开发，加速 3D 生物列印的采用。

市场限制因素：

儘管潜力巨大，3D 生物列印市场仍面临初始成本高、技术复杂性和监管障碍等课题。该技术需要在设备、材料和专业知识方面进行大量投资，这对小型研究机构和公司来说可能是一个障碍。生物列印组织和器官的监管批准也是一个课题，必须满足严格的安全和道德标准。此外，还必须解决有关生物相容性、可扩展性和可重复性的问题，以确保市场的持续成长。

市场机会：

3D生物列印市场存在许多创新和扩张的机会。新生物材料和生物列印技术的发展为创造更复杂和功能性的组织打开了大门。研究机构、大学和行业参与者之间的合作伙伴关係可以加速创新并推动市场成长。生物列印在製药领域具有巨大潜力，因为它可以实现更准确的药物测试和个人化医疗方法。此外，人们对再生医学和器官移植等替代医学的兴趣日益浓厚，为公司开发新型生物列印应用创造了机会。

本报告解决的关键问题

  • 3D生物列印市场的预期复合年增长率是多少？
  • 推动生物3D列印市场成长的因素有哪些？
  • 哪个地区在3D生物列印市场中占据最大的市场占有率？
  • 谁是全球3D生物列印市场的主要参与者？
  • 3D生物列印市场的主要课题和商机是什么？

目录

第一章执行摘要

第二章市场概况

  • 市场范围/分类
  • 市场定义/范围/限制

第 3 章主要市场趋势

  • 影响市场的主要趋势
  • 产品创新/发展趋势

第 4 章 关键成功因素

  • 产品采用/使用分析
  • 产品 USP/特点
  • 战略推广策略

第五章全球3D生物列印市场需求分析

  • 过去的市场规模（吨）分析，2019-2023
  • 2024-2031 年当前和未来市场量（吨）预测
  • 同比增长趋势分析

第六章全球3D生物列印市场-价格分析

  • 依组成部分的区域价格分析
  • 全球平均价格分析基准

第七章全球3D生物列印市场需求（数量与规模）分析

  • 过去的市场（金额）分析，2019-2023
  • 当前和未来市场（价值）预测，2024-2031

第八章市场背景

  • 宏观经济因素
  • 预测变量 - 相关性和影响
  • 价值链
  • COVID-19 危机 - 影响评估
  • 市场动态

第 9 章全球 3D 生物列印市场分析：依组成部分

  • 简介/主要发现
  • 过去的市场规模（金额）和数量分析，2019-2023
  • 目前和未来的市场规模（金额）和定量分析/预测，2024-2031
    • 3D生物打印机
    • 生物墨水
  • 依组件划分的市场吸引力分析

第10章全球3D生物列印市场应用分析

  • 简介/主要发现
  • 过去的市场规模（金额）和数量分析，2019-2023
  • 目前和未来的市场规模（金额）和定量分析/预测，2024-2031
    • 调查使用
    • 临床应用
  • 依应用划分的市场吸引力分析

第 11 章 全球 3D 生物列印市场分析：依最终使用者分类

  • 简介/主要发现
  • 过去的市场规模（美国）和最终用户数量分析，2019-2023
  • 依当前和未来市场规模（美国）和最终用户在 2024-2031 年进行的数量分析和预测
    • 研究和学术机构
    • 生物製药公司
    • 医院
  • 最终用户的市场吸引力分析

第 12 章 3D 生物列印市场分析：依地区

  • 介绍
  • 过去的市场规模（金额）和数量分析，2019-2023
  • 当前市场规模（金额）和数量分析/预测，2024-2031
    • 北美
    • 拉丁美洲
    • 欧洲
    • 东亚
    • 南亚和太平洋地区
    • 中东和非洲 (MEA)
  • 区域市场吸引力分析

第十三章北美3D生物列印市场分析

第14章拉丁美洲3D生物列印市场分析

第十五章欧洲3D生物列印市场分析

第十六章南亚和太平洋地区3D生物列印市场分析

第十七章东亚3D生物列印市场分析

第十八章中东与非洲3D生物列印市场分析

第十九章新兴国家3D生物列印市场分析

  • 介绍
    • 主要国家市值占比分析
    • 全球和国家成长比较
  • 美国3D生物列印市场分析
    • 依类型
    • 依用途
    • 依最终用户
  • 加拿大3D生物列印市场分析
    • 依类型
    • 依用途
    • 依最终用户
  • 墨西哥3D生物列印市场分析
    • 依类型
    • 依用途
    • 依最终用户
  • 巴西3D生物列印市场分析
    • 依类型
    • 依用途
    • 依最终用户
  • 德国3D生物列印市场分析
    • 依类型
    • 依用途
    • 依最终用户
  • 义大利3D生物列印市场分析
    • 依类型
    • 依用途
    • 依最终用户
  • 法国3D生物列印市场分析
    • 依类型
    • 依用途
    • 依最终用户
  • 英国3D生物列印市场分析
    • 依类型
    • 依用途
    • 依最终用户
  • 西班牙3D生物列印市场分析
    • 依类型
    • 依用途
    • 依最终用户
  • 比荷卢经济联盟3D生物列印市场分析
    • 依类型
    • 依用途
    • 依最终用户
  • 俄罗斯3D生物列印市场分析
    • 依类型
    • 依用途
    • 依最终用户
  • 中国3D生物列印市场分析
    • 依类型
    • 依用途
    • 依最终用户
  • 日本3D生物列印市场分析
    • 依类型
    • 依用途
    • 依最终用户
  • 韩国3D生物列印市场分析
    • 依类型
    • 依用途
    • 依最终用户
  • 印度3D生物列印市场分析
    • 依类型
    • 依用途
    • 依最终用户
  • 东协3D生物列印市场分析
    • 依类型
    • 依用途
    • 依最终用户
  • 澳洲和纽西兰3D生物列印市场分析
    • 依类型
    • 依用途
    • 依最终用户
  • GCC 国家 3D 生物列印市场分析
    • 依类型
    • 依用途
    • 依最终用户
  • 土耳其3D生物列印市场分析
    • 依类型
    • 依用途
    • 依最终用户
  • 北非3D生物列印市场分析
    • 依类型
    • 依用途
    • 依最终用户
  • 南非3D生物列印市场分析
    • 依类型
    • 依用途
    • 依最终用户

第二十章市场结构分析

  • 依公司层级进行市场分析
  • 主要参与者的市场占有率分析
  • 市场存在分析

第 21 章 竞争分析

  • 比赛仪表板
  • 竞争标桿
  • 衝突详情
    • Envisiontec, Inc.
    • Precise Bio
    • Organovo Holdings, Inc.
    • Revotek Co., Ltd.
    • Inventia Life Science PTY LTD
    • Vivax Bio
    • Poietis
    • Allevi
    • Biomedical KK
    • Cellink Global
    • Bioprinting Solutions

第 22 章使用的假设和首字母缩略词

第23章研究方法论

简介目录
Product Code: PMRREP3255

Persistence Market Research has released an in-depth analysis of the global 3D Bioprinting Market, providing insights into the key market dynamics, growth drivers, challenges, and emerging trends from 2024 through 2031. The report aims to equip stakeholders with detailed data and statistical information to guide strategic decision-making within this evolving sector.

The global 3D bioprinting market is expected to experience rapid growth, with a projected CAGR of 15% between 2024 and 2031. This growth is set to increase the market's value from an estimated USD 2.5 billion in 2024 to approximately USD 6.6 billion by the end of 2031.

Key Insights:

  • Estimated Market Value (2024): USD 2.5 Billion
  • Projected Market Value (2031): USD 6.6 Billion
  • Global Market Growth Rate (CAGR 2024 to 2031): 15%

3D Bioprinting Market - Report Scope:

3D bioprinting technology allows for the creation of complex biological structures using additive manufacturing processes. It has emerged as a significant tool in tissue engineering, regenerative medicine, and pharmaceutical research. The rapid advancement in technology and the increasing demand for organ transplantation alternatives have driven the growth of this market. The scope of this report encompasses the ongoing developments in 3D bioprinting, its applications in various sectors, and the broader trends shaping the industry.

Market Growth Drivers:

The rapid growth in the 3D bioprinting market is driven by several factors. The growing need for organ transplantation and the shortage of donor organs are leading researchers to explore 3D bioprinting as an alternative. Advancements in materials and bioprinting techniques enable the creation of complex tissue structures, expanding the possibilities in regenerative medicine. Additionally, the pharmaceutical industry is adopting 3D bioprinting for drug testing and development, allowing for more precise and cost-effective research. Furthermore, government funding and academic research are contributing to technological innovation and new product development, accelerating the adoption of 3D bioprinting.

Market Restraints:

Despite the potential, the 3D bioprinting market faces challenges such as high initial costs, technical complexities, and regulatory hurdles. The technology requires significant investment in equipment, materials, and expertise, which can be a barrier for smaller research institutions and companies. Regulatory approval for bioprinted tissues and organs is another challenge, with strict safety and ethical standards to meet. Additionally, issues related to biocompatibility, scalability, and reproducibility must be addressed to ensure the market's sustained growth.

Market Opportunities:

The 3D bioprinting market presents numerous opportunities for innovation and expansion. The development of new biomaterials and bioprinting techniques opens doors for creating more complex and functional tissues. Collaborative partnerships between research institutions, universities, and industry players can accelerate innovation and drive market growth. The pharmaceutical sector offers significant potential, with bioprinting enabling more accurate drug testing and personalized medicine approaches. Furthermore, the increasing interest in regenerative medicine and organ transplantation alternatives creates opportunities for companies to develop novel bioprinting applications.

Key Questions Addressed in the Report:

  • What is the Expected Value CAGR of the 3D Bioprinting Market?
  • What are the Key Drivers Contributing to the Growth of the 3D Bioprinting Market?
  • Which Regions Hold the Largest Market Share in the 3D Bioprinting Market?
  • Who are the Key Players in the Global 3D Bioprinting Market?
  • What Are the Main Challenges and Opportunities in the 3D Bioprinting Market?

Competitive Landscape and Business Strategies:

Leading companies in the 3D bioprinting market, such as Organovo Holdings, Inc., 3D Systems, Inc., and CELLINK, focus on innovation, strategic partnerships, and product development to stay competitive. These companies invest heavily in research and development to improve bioprinting techniques and expand their product portfolios. Collaborations with academic institutions and pharmaceutical companies enable them to access new technologies and markets. Additionally, strategic acquisitions and partnerships with healthcare providers allow these companies to strengthen their market presence and broaden their customer base.

Key Companies Profiled:

  • Envisiontec, Inc.
  • Precise Bio
  • Organovo Holdings, Inc.
  • Revotek Co., Ltd.
  • Inventia Life Science PTY LTD
  • Vivax Bio
  • Poietis
  • Allevi
  • Biomedical K.K.
  • Cellink Global
  • Bioprinting Solutions

3D Bioprinting Market Segmentation:

By Component:

  • 3D Bioprinters
  • Bioinks

By Application:

  • Research Applications
  • Clinical Applications

By End User:

  • Research Organization and Academic Institutes
  • Biopharmaceutical Companies
  • Hospitals

By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Technology Roadmap
  • 1.5. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Product Innovation / Development Trends

4. Key Success Factors

  • 4.1. Product Adoption / Usage Analysis
  • 4.2. Product USPs / Features
  • 4.3. Strategic Promotional Strategies

5. Global 3D Bioprinting Market Demand Analysis 2019-2023 and Forecast, 2024-2031

  • 5.1. Historical Market Volume (Tons) Analysis, 2019-2023
  • 5.2. Current and Future Market Volume (Tons) Projections, 2024-2031
  • 5.3. Y-o-Y Growth Trend Analysis

6. Global 3D Bioprinting Market - Pricing Analysis

  • 6.1. Regional Pricing Analysis By Component
  • 6.2. Global Average Pricing Analysis Benchmark

7. Global 3D Bioprinting Market Demand (in Value or Size in US$ Mn) Analysis 2019-2023 and Forecast, 2024-2031

  • 7.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
  • 7.2. Current and Future Market Value (US$ Mn) Projections, 2024-2031
    • 7.2.1. Y-o-Y Growth Trend Analysis
    • 7.2.2. Absolute $ Opportunity Analysis

8. Market Background

  • 8.1. Macro-Economic Factors
    • 8.1.1. Global GDP Growth Outlook
    • 8.1.2. Global Industry Value Added Overview
    • 8.1.3. Global Infrastructure Investment Overview
    • 8.1.4. Global Construction Spending Analysis
    • 8.1.5. Other Macro Economic Factors
  • 8.2. Forecast Factors - Relevance & Impact
    • 8.2.1. Top Companies Historical Growth
    • 8.2.2. GDP Growth forecast
    • 8.2.3. Construction Industry forecast
    • 8.2.4. End User Growth Outlook
    • 8.2.5. Collaboration Activities
  • 8.3. Value Chain
    • 8.3.1. Raw Material Suppliers
    • 8.3.2. List of Manufacturers
    • 8.3.3. List of Distributors
  • 8.4. COVID-19 Crisis - Impact Assessment
    • 8.4.1. Current Statistics
    • 8.4.2. Short-Mid-Long Term Outlook
    • 8.4.3. Likely Rebound
  • 8.5. Market Dynamics
    • 8.5.1. Drivers
    • 8.5.2. Restraints
    • 8.5.3. Opportunity Analysis
    • 8.5.4. Trends

9. Global 3D Bioprinting Market Analysis 2019-2023 and Forecast 2024-2031, by Component

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Mn) and Volume Analysis by Type, 2019-2023
  • 9.3. Current and Future Market Size (US$ Mn) and Volume Analysis and Forecast by Component 2024-2031
    • 9.3.1. 3D Bioprinters
    • 9.3.2. Bioinks
  • 9.4. Market Attractiveness Analysis by Component

10. Global 3D Bioprinting Market Analysis 2019-2023 and Forecast 2024-2031, By Application

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Mn) and Volume Analysis By Application, 2019-2023
  • 10.3. Current and Future Market Size (US$ Mn) and Volume Analysis and Forecast By Application, 2024-2031
    • 10.3.1. Research Applications
    • 10.3.2. Clinical Applications
  • 10.4. Market Attractiveness Analysis By Application

11. Global 3D Bioprinting Market Analysis 2019-2023 and Forecast 2024-2031, By End User

  • 11.1. Introduction / Key Findings
  • 11.2. Historical Market Size (US$ Mn) and Volume Analysis By End User, 2019-2023
  • 11.3. Current and Future Market Size (US$ Mn) and Volume Analysis and Forecast By End User 2024-2031
    • 11.3.1. Research Organization and Academic Institutes
    • 11.3.2. Biopharmaceutical Companies
    • 11.3.3. Hospitals
  • 11.4. Market Attractiveness Analysis By End User

12. Global 3D Bioprinting Market Analysis 2019-2023 and Forecast 2024-2031, by Region

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Mn) and Volume Analysis by Region, 2019-2023
  • 12.3. Current Market Size (US$ Mn) and Volume Analysis and Forecast by Region, 2024-2031
    • 12.3.1. North America
    • 12.3.2. Latin America
    • 12.3.3. Europe
    • 12.3.4. East Asia
    • 12.3.5. South Asia and Pacific
    • 12.3.6. Middle East and Africa (MEA)
  • 12.4. Market Attractiveness Analysis By Region

13. North America 3D Bioprinting Market Analysis 2019-2023 and Forecast 2024-2031

  • 13.1. Introduction
  • 13.2. Pricing Analysis
  • 13.3. Historical Market Size (US$ Mn) and Volume Trend Analysis by Market Taxonomy, 2019-2023
  • 13.4. Market Size (US$ Mn) and Volume Forecast by Market Taxonomy, 2024-2031
    • 13.4.1. By Country
      • 13.4.1.1. U.S.
      • 13.4.1.2. Canada
    • 13.4.2. By Type
    • 13.4.3. By Application
    • 13.4.4. By End User
  • 13.5. Market Attractiveness Analysis
    • 13.5.1. By Country
    • 13.5.2. By Type
    • 13.5.3. By Application
    • 13.5.4. By End User
  • 13.6. Market Trends
  • 13.7. Key Market Participants - Intensity Mapping
  • 13.8. Drivers and Restraints - Impact Analysis

14. Latin America 3D Bioprinting Market Analysis 2019-2023 and Forecast 2024-2031

  • 14.1. Introduction
  • 14.2. Pricing Analysis
  • 14.3. Historical Market Size (US$ Mn) and Volume Trend Analysis by Market Taxonomy, 2019-2023
  • 14.4. Market Size (US$ Mn) and Volume Forecast by Market Taxonomy, 2024-2031
    • 14.4.1. By Country
      • 14.4.1.1. Brazil
      • 14.4.1.2. Mexico
      • 14.4.1.3. Rest of Latin America
    • 14.4.2. By Type
    • 14.4.3. By Application
    • 14.4.4. By End User
  • 14.5. Market Attractiveness Analysis
    • 14.5.1. By Country
    • 14.5.2. By Type
    • 14.5.3. By Application
    • 14.5.4. By End User
  • 14.6. Market Trends
  • 14.7. Key Market Participants - Intensity Mapping
  • 14.8. Drivers and Restraints - Impact Analysis

15. Europe 3D Bioprinting Market Analysis 2019-2023 and Forecast 2024-2031

  • 15.1. Introduction
  • 15.2. Pricing Analysis
  • 15.3. Historical Market Size (US$ Mn) and Volume Trend Analysis by Market Taxonomy, 2019-2023
  • 15.4. Market Size (US$ Mn) and Volume Forecast by Market Taxonomy, 2024-2031
    • 15.4.1. By Country
      • 15.4.1.1. Germany
      • 15.4.1.2. Italy
      • 15.4.1.3. France
      • 15.4.1.4. U.K.
      • 15.4.1.5. Spain
      • 15.4.1.6. BENELUX
      • 15.4.1.7. Russia
      • 15.4.1.8. Rest of Europe
    • 15.4.2. By Type
    • 15.4.3. By Application
    • 15.4.4. By End User
  • 15.5. Market Attractiveness Analysis
    • 15.5.1. By Country
    • 15.5.2. By Type
    • 15.5.3. By Application
    • 15.5.4. By End User
  • 15.6. Market Trends
  • 15.7. Key Market Participants - Intensity Mapping
  • 15.8. Drivers and Restraints - Impact Analysis

16. South Asia and Pacific 3D Bioprinting Market Analysis 2019-2023 and Forecast 2024-2031

  • 16.1. Introduction
  • 16.2. Pricing Analysis
  • 16.3. Historical Market Size (US$ Mn) and Volume Trend Analysis by Market Taxonomy, 2019-2023
  • 16.4. Market Size (US$ Mn) and Volume Forecast by Market Taxonomy, 2024-2031
    • 16.4.1. By Country
      • 16.4.1.1. India
      • 16.4.1.2. ASEAN
      • 16.4.1.3. Oceania
      • 16.4.1.4. Rest of South Asia & Pacific
    • 16.4.2. By Type
    • 16.4.3. By Application
    • 16.4.4. By End User
  • 16.5. Market Attractiveness Analysis
    • 16.5.1. By Country
    • 16.5.2. By Type
    • 16.5.3. By Application
    • 16.5.4. By End User
  • 16.6. Market Trends
  • 16.7. Key Market Participants - Intensity Mapping
  • 16.8. Drivers and Restraints - Impact Analysis

17. East Asia 3D Bioprinting Market Analysis 2019-2023 and Forecast 2024-2031

  • 17.1. Introduction
  • 17.2. Pricing Analysis
  • 17.3. Historical Market Size (US$ Mn) and Volume Trend Analysis by Market Taxonomy, 2019-2023
  • 17.4. Market Size (US$ Mn) and Volume Forecast by Market Taxonomy, 2024-2031
    • 17.4.1. By Country
      • 17.4.1.1. China
      • 17.4.1.2. Japan
      • 17.4.1.3. South Korea
    • 17.4.2. By Type
    • 17.4.3. By Application
    • 17.4.4. By End User
  • 17.5. Market Attractiveness Analysis
    • 17.5.1. By Country
    • 17.5.2. By Type
    • 17.5.3. By Application
    • 17.5.4. By End User
  • 17.6. Market Trends
  • 17.7. Key Market Participants - Intensity Mapping
  • 17.8. Drivers and Restraints - Impact Analysis

18. Middle East and Africa 3D Bioprinting Market Analysis 2019-2023 and Forecast 2024-2031

  • 18.1. Introduction
  • 18.2. Pricing Analysis
  • 18.3. Historical Market Size (US$ Mn) and Volume Trend Analysis by Market Taxonomy, 2019-2023
  • 18.4. Market Size (US$ Mn) and Volume Forecast by Market Taxonomy, 2024-2031
    • 18.4.1. By Country
      • 18.4.1.1. GCC Countries
      • 18.4.1.2. Turkey
      • 18.4.1.3. Northern Africa
      • 18.4.1.4. South Africa
      • 18.4.1.5. Rest of Middle East and Africa
    • 18.4.2. By Type
    • 18.4.3. By Application
    • 18.4.4. By End User
  • 18.5. Market Attractiveness Analysis
    • 18.5.1. By Country
    • 18.5.2. By Type
    • 18.5.3. By Application
    • 18.5.4. By End User
  • 18.6. Market Trends
  • 18.7. Key Market Participants - Intensity Mapping
  • 18.8. Drivers and Restraints - Impact Analysis

19. Emerging Countries 3D Bioprinting Market Analysis

  • 19.1. Introduction
    • 19.1.1. Market Value Proportion Analysis, By Key Countries
    • 19.1.2. Global Vs. Country Growth Comparison
  • 19.2. U.S. 3D Bioprinting Market Analysis
    • 19.2.1. By Type
    • 19.2.2. By Application
    • 19.2.3. By End User
  • 19.3. Canada 3D Bioprinting Market Analysis
    • 19.3.1. By Type
    • 19.3.2. By Application
    • 19.3.3. By End User
  • 19.4. Mexico 3D Bioprinting Market Analysis
    • 19.4.1. By Type
    • 19.4.2. By Application
    • 19.4.3. By End User
  • 19.5. Brazil 3D Bioprinting Market Analysis
    • 19.5.1. By Type
    • 19.5.2. By Application
    • 19.5.3. By End User
  • 19.6. Germany 3D Bioprinting Market Analysis
    • 19.6.1. By Type
    • 19.6.2. By Application
    • 19.6.3. By End User
  • 19.7. Italy 3D Bioprinting Market Analysis
    • 19.7.1. By Type
    • 19.7.2. By Application
    • 19.7.3. By End User
  • 19.8. France 3D Bioprinting Market Analysis
    • 19.8.1. By Type
    • 19.8.2. By Application
    • 19.8.3. By End User
  • 19.9. U.K. 3D Bioprinting Market Analysis
    • 19.9.1. By Type
    • 19.9.2. By Application
    • 19.9.3. By End User
  • 19.10. Spain 3D Bioprinting Market Analysis
    • 19.10.1. By Type
    • 19.10.2. By Application
    • 19.10.3. By End User
  • 19.11. BENELUX 3D Bioprinting Market Analysis
    • 19.11.1. By Type
    • 19.11.2. By Application
    • 19.11.3. By End User
  • 19.12. Russia 3D Bioprinting Market Analysis
    • 19.12.1. By Type
    • 19.12.2. By Application
    • 19.12.3. By End User
  • 19.13. China 3D Bioprinting Market Analysis
    • 19.13.1. By Type
    • 19.13.2. By Application
    • 19.13.3. By End User
  • 19.14. Japan 3D Bioprinting Market Analysis
    • 19.14.1. By Type
    • 19.14.2. By Application
    • 19.14.3. By End User
  • 19.15. S. Korea 3D Bioprinting Market Analysis
    • 19.15.1. By Type
    • 19.15.2. By Application
    • 19.15.3. By End User
  • 19.16. India 3D Bioprinting Market Analysis
    • 19.16.1. By Type
    • 19.16.2. By Application
    • 19.16.3. By End User
  • 19.17. ASEAN 3D Bioprinting Market Analysis
    • 19.17.1. By Type
    • 19.17.2. By Application
    • 19.17.3. By End User
  • 19.18. Australia and New Zealand 3D Bioprinting Market Analysis
    • 19.18.1. By Type
    • 19.18.2. By Application
    • 19.18.3. By End User
  • 19.19. GCC Countries 3D Bioprinting Market Analysis
    • 19.19.1. By Type
    • 19.19.2. By Application
    • 19.19.3. By End User
  • 19.20. Turkey 3D Bioprinting Market Analysis
    • 19.20.1. By Type
    • 19.20.2. By Application
    • 19.20.3. By End User
  • 19.21. Northern Africa 3D Bioprinting Market Analysis
    • 19.21.1. By Type
    • 19.21.2. By Application
    • 19.21.3. By End User
  • 19.22. South Africa 3D Bioprinting Market Analysis
    • 19.22.1. By Type
    • 19.22.2. By Application
    • 19.22.3. By End User

20. Market Structure Analysis

  • 20.1. Market Analysis by Tier of Companies (Linear Alpha-Olefins)
  • 20.2. Market Share Analysis of Top Players
  • 20.3. Market Presence Analysis

21. Competition Analysis

  • 21.1. Competition Dashboard
  • 21.2. Competition Benchmarking
  • 21.3. Competition Deep Dive
    • 21.3.1. Envisiontec, Inc.
      • 21.3.1.1. Overview
      • 21.3.1.2. Product Portfolio
      • 21.3.1.3. Profitability by Market Segments (Product/Channel/Region)
      • 21.3.1.4. Sales Footprint
      • 21.3.1.5. Strategy Overview
    • 21.3.2. Precise Bio
      • 21.3.2.1. Overview
      • 21.3.2.2. Product Portfolio
      • 21.3.2.3. Profitability by Market Segments (Product/Channel/Region)
      • 21.3.2.4. Sales Footprint
      • 21.3.2.5. Strategy Overview
    • 21.3.3. Organovo Holdings, Inc.
      • 21.3.3.1. Overview
      • 21.3.3.2. Product Portfolio
      • 21.3.3.3. Profitability by Market Segments (Product/Channel/Region)
      • 21.3.3.4. Sales Footprint
      • 21.3.3.5. Strategy Overview
    • 21.3.4. Revotek Co., Ltd.
      • 21.3.4.1. Overview
      • 21.3.4.2. Product Portfolio
      • 21.3.4.3. Profitability by Market Segments (Product/Channel/Region)
      • 21.3.4.4. Sales Footprint
      • 21.3.4.5. Strategy Overview
    • 21.3.5. Inventia Life Science PTY LTD
      • 21.3.5.1. Overview
      • 21.3.5.2. Product Portfolio
      • 21.3.5.3. Profitability by Market Segments (Product/Channel/Region)
      • 21.3.5.4. Sales Footprint
      • 21.3.5.5. Strategy Overview
    • 21.3.6. Vivax Bio
      • 21.3.6.1. Overview
      • 21.3.6.2. Product Portfolio
      • 21.3.6.3. Profitability by Market Segments (Product/Channel/Region)
      • 21.3.6.4. Sales Footprint
      • 21.3.6.5. Strategy Overview
    • 21.3.7. Poietis
      • 21.3.7.1. Overview
      • 21.3.7.2. Product Portfolio
      • 21.3.7.3. Profitability by Market Segments (Product/Channel/Region)
      • 21.3.7.4. Sales Footprint
      • 21.3.7.5. Strategy Overview
    • 21.3.8. Allevi
      • 21.3.8.1. Overview
      • 21.3.8.2. Product Portfolio
      • 21.3.8.3. Profitability by Market Segments (Product/Channel/Region)
      • 21.3.8.4. Sales Footprint
      • 21.3.8.5. Strategy Overview
    • 21.3.9. Biomedical K.K.
      • 21.3.9.1. Overview
      • 21.3.9.2. Product Portfolio
      • 21.3.9.3. Profitability by Market Segments (Product/Channel/Region)
      • 21.3.9.4. Sales Footprint
      • 21.3.9.5. Strategy Overview
    • 21.3.10. Cellink Global
      • 21.3.10.1. Overview
      • 21.3.10.2. Product Portfolio
      • 21.3.10.3. Profitability by Market Segments (Product/Channel/Region)
      • 21.3.10.4. Sales Footprint
      • 21.3.10.5. Strategy Overview
    • 21.3.11. Bioprinting Solutions
      • 21.3.11.1. Overview
      • 21.3.11.2. Product Portfolio
      • 21.3.11.3. Profitability by Market Segments (Product/Channel/Region)
      • 21.3.11.4. Sales Footprint
      • 21.3.11.5. Strategy Overview

22. Assumptions and Acronyms Used

23. Research Methodology